Abstract
Bioscience ventures in Central and Eastern Europe are becoming a presence in world healthcare markets despite a perennially short supply of venture funding and other support mechanisms relative to other world economic regions. Here are three up-and-coming CEE stories worth keeping an eye on.
Conflict of Interest
Landes Bioscience owns equity in MedicAlgorithmics and ImmunoGenes.